We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Says Fresenius Can Pull Out of Akorn Acquisition
Court Says Fresenius Can Pull Out of Akorn Acquisition
A Delaware court on Monday sided with Fresenius in its bid to pull out of a planned $4.3 billion merger with Akorn because of alleged fraud and falsified testing data submitted to the FDA.